Nurix Therapeutics, Inc. (NRIX)
22.14
-0.21
(-0.94%)
USD |
NASDAQ |
Oct 12, 16:00
22.52
+0.38
(+1.72%)
After-Hours: 19:33
Nurix Therapeutics Price : 22.14 for Oct. 12, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 09, 2026 | 22.04 | 23.23 | 21.23 | 22.35 | 1.525M |
| Oct 08, 2026 | 22.49 | 22.60 | 21.55 | 22.21 | 2.345M |
| Oct 07, 2026 | 22.43 | 23.10 | 22.18 | 22.73 | 1.632M |
| Oct 06, 2026 | 23.06 | 23.06 | 22.10 | 22.60 | 1.154M |
| Oct 05, 2026 | 22.81 | 23.31 | 22.42 | 22.88 | 1.007M |
| Oct 02, 2026 | 23.72 | 23.74 | 22.85 | 22.99 | 815509.0 |
| Oct 01, 2026 | 23.60 | 23.98 | 23.21 | 23.34 | 1.335M |
| Sep 30, 2026 | 23.85 | 23.94 | 23.34 | 23.71 | 2.011M |
| Sep 29, 2026 | 23.57 | 23.91 | 23.24 | 23.68 | 2.275M |
| Sep 28, 2026 | 22.86 | 23.69 | 22.41 | 23.67 | 2.008M |
| Sep 25, 2026 | 23.78 | 23.80 | 22.98 | 23.01 | 1.540M |
| Sep 24, 2026 | 23.76 | 23.93 | 23.02 | 23.65 | 2.023M |
| Sep 23, 2026 | 25.49 | 25.56 | 23.85 | 23.88 | 1.364M |
| Sep 22, 2026 | 25.32 | 25.96 | 25.23 | 25.67 | 1.510M |
| Sep 21, 2026 | 25.73 | 25.92 | 25.06 | 25.41 | 1.517M |
| Sep 18, 2026 | 25.32 | 25.80 | 25.01 | 25.44 | 2.840M |
| Sep 17, 2026 | 25.79 | 26.35 | 25.37 | 25.50 | 1.512M |
| Sep 16, 2026 | 24.87 | 25.29 | 24.68 | 25.15 | 1.236M |
| Sep 15, 2026 | 25.47 | 25.50 | 24.27 | 24.83 | 1.251M |
| Sep 14, 2026 | 25.01 | 26.14 | 24.94 | 25.52 | 1.331M |
| Sep 11, 2026 | 26.31 | 26.65 | 25.00 | 25.10 | 1.322M |
| Sep 10, 2026 | 25.89 | 25.99 | 25.50 | 25.81 | 1.029M |
| Sep 09, 2026 | 26.46 | 26.70 | 25.91 | 26.26 | 1.028M |
| Sep 08, 2026 | 25.42 | 26.42 | 25.36 | 26.13 | 1.288M |
| Sep 04, 2026 | 25.19 | 26.22 | 24.97 | 26.14 | 1.232M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Gilead Sciences, Inc. | 150.44 |
| ACADIA Pharmaceuticals, Inc. | 19.41 |
| Alnylam Pharmaceuticals, Inc. | 227.05 |
| Anika Therapeutics, Inc. | 20.67 |
| Savara, Inc. | 4.835 |
Price Related Metrics
| PS Ratio | 60.28 |
| PEG Ratio | -0.2008 |
| Price to Book Value | 5.702 |
| Earnings Yield | -15.57% |
| Market Cap | 2.296B |
| PEGY Ratio | -0.2008 |